Drug Shortage Report for TEVA-MONTELUKAST
| Report ID | 93134 |
| Drug Identification Number | 02355515 |
| Brand name | TEVA-MONTELUKAST |
| Common or Proper name | MONTELUKAST |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MONTELUKAST |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET (CHEWABLE) |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | R03DC |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-09-05 |
| Estimated end date | 2019-09-30 |
| Actual end date | 2019-09-26 |
| Shortage status | Resolved |
| Updated date | 2019-09-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2019-09-27 | English | Compare |
| v5 | 2019-09-26 | French | Compare |
| v4 | 2019-09-26 | English | Compare |
| v3 | 2019-09-06 | English | Compare |
| v2 | 2019-09-05 | French | Compare |
| v1 | 2019-09-05 | English | Compare |
Showing 1 to 6 of 6